A Single Intravenous Injection of an AAV-PHP. B Vector Encoding Human Acid alpha-Glucosidase Corrects Both Muscle and Brain Defects in Murine Pompe Disease
Publication
, Conference
Lim, J-A; Yi, H; Gao, F; Kishinani, P; Sun, B
Published in: MOLECULAR THERAPY
May 1, 2018
Duke Scholars
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2018
Volume
26
Issue
5
Start / End Page
382 / 383
Location
Chicago, IL
Publisher
CELL PRESS
Conference Name
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Lim, J.-A., Yi, H., Gao, F., Kishinani, P., & Sun, B. (2018). A Single Intravenous Injection of an AAV-PHP. B Vector Encoding Human Acid alpha-Glucosidase Corrects Both Muscle and Brain Defects in Murine Pompe Disease. In MOLECULAR THERAPY (Vol. 26, pp. 382–383). Chicago, IL: CELL PRESS.
Lim, Jeong-A, Haiqing Yi, Fengqin Gao, Priya Kishinani, and Baodong Sun. “A Single Intravenous Injection of an AAV-PHP. B Vector Encoding Human Acid alpha-Glucosidase Corrects Both Muscle and Brain Defects in Murine Pompe Disease.” In MOLECULAR THERAPY, 26:382–83. CELL PRESS, 2018.
Lim J-A, Yi H, Gao F, Kishinani P, Sun B. A Single Intravenous Injection of an AAV-PHP. B Vector Encoding Human Acid alpha-Glucosidase Corrects Both Muscle and Brain Defects in Murine Pompe Disease. In: MOLECULAR THERAPY. CELL PRESS; 2018. p. 382–3.
Lim, Jeong-A., et al. “A Single Intravenous Injection of an AAV-PHP. B Vector Encoding Human Acid alpha-Glucosidase Corrects Both Muscle and Brain Defects in Murine Pompe Disease.” MOLECULAR THERAPY, vol. 26, no. 5, CELL PRESS, 2018, pp. 382–83.
Lim J-A, Yi H, Gao F, Kishinani P, Sun B. A Single Intravenous Injection of an AAV-PHP. B Vector Encoding Human Acid alpha-Glucosidase Corrects Both Muscle and Brain Defects in Murine Pompe Disease. MOLECULAR THERAPY. CELL PRESS; 2018. p. 382–383.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2018
Volume
26
Issue
5
Start / End Page
382 / 383
Location
Chicago, IL
Publisher
CELL PRESS
Conference Name
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences